Natalie Nardone, PhD

Title(s)Project Manager, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Benowitz NL, Helen GS, Nardone N, Cox LS, Jacob P. Urine Metabolites for Estimating Daily Intake of Nicotine from Cigarette Smoking. Nicotine Tob Res. 2019 Mar 10. PMID: 30852610.
      View in: PubMed
    2. Nardone, N., Benowitz, N.L., Smith, T.T., Denlinger-Apte, R., Hatsukami, D., Koopmeiners, J.S., et al. .Tobacco Regulatory Science. Reasons for Non-Compliance in a Trial of Reduced Nicotine Cigarettes. 2019; 5:87-93.
    3. Nardone, N., Ko, J., St. Helen, G. Benowitz, N. .Tobacco Regulatory Science. Nicotine Intake, Dependence, and Characteristics of Electronic Cigarette and Dual Users. 2019; 5:27-35.
    4. Liakoni E, Edwards KC, St Helen G, Nardone N, Dempsey DA, Tyndale RF, Benowitz NL. Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence. Clin Pharmacol Ther. 2019 Mar; 105(3):641-651. PMID: 30242831.
      View in: PubMed
    5. St Helen G, Jacob Iii P, Nardone N, Benowitz NL. IQOS: examination of Philip Morris International's claim of reduced exposure. Tob Control. 2018 11; 27(Suppl 1):s30-s36. PMID: 30158205.
      View in: PubMed
    6. Benowitz NL, Nardone N, Jain S, Dempsey DA, Addo N, St Helen G, Jacob P. Comparison of Urine 4-(Methylnitrosamino)-1-(3)Pyridyl-1-Butanol and Cotinine for Assessment of Active and Passive Smoke Exposure in Urban Adolescents. Cancer Epidemiol Biomarkers Prev. 2018 03; 27(3):254-261. PMID: 29475963.
      View in: PubMed
    7. Benowitz NL, Jain S, Dempsey DA, Nardone N, Helen GS, Jacob P. Urine Cotinine Screening Detects Nearly Ubiquitous Tobacco Smoke Exposure in Urban Adolescents. Nicotine Tob Res. 2017 Sep 01; 19(9):1048-1054. PMID: 28031377.
      View in: PubMed
    8. Nardone N, Donny EC, Hatsukami DK, Koopmeiners JS, Murphy SE, Strasser AA, Tidey JW, Vandrey R, Benowitz NL. Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes. Addiction. 2016 12; 111(12):2208-2216. PMID: 27367436.
      View in: PubMed
    9. Benowitz NL, Nardone N, Dains KM, Hall SM, Stewart S, Dempsey D, Jacob P. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. Addiction. 2015 Oct; 110(10):1667-75. PMID: 26198394; PMCID: PMC4565734 [Available on 10/01/16].
    10. Benowitz NL, Nardone N, Hatsukami DK, Donny EC. Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):331-5. PMID: 25416718; PMCID: PMC4323626.
    11. Homayounfar G, Borkar DS, Tham VM, Nardone N, Acharya NR. Clinical characteristics of scleritis and episcleritis: results from the pacific ocular inflammation study. Ocul Immunol Inflamm. 2014 Oct; 22(5):403-4. PMID: 24295070.
      View in: PubMed
    12. Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, Parker JV, Vinoya AC, Uchida A, Acharya NR. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013 Oct; 156(4):752-8. PMID: 23891336; PMCID: PMC3852161.
    13. Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci. 2013 Feb 28; 54(2):1522-6. PMID: 23385795; PMCID: PMC4136376.